Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomicsMAYER, Erica L; ISAKOFF, Steven J; KLEMENT, Giannoula et al.Breast cancer research and treatment. 2012, Vol 136, Num 1, pp 169-178, issn 0167-6806, 10 p.Article

Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease HeterogeneityBELTRAN, Himisha; YELENSKY, Roman; STEPHENS, Philip J et al.European urology. 2013, Vol 63, Num 5, pp 920-926, issn 0302-2838, 7 p.Article

A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial CarcinomaROSS, Jeffrey S; KAI WANG; PALMER, Gary et al.Clinical cancer research (Print). 2014, Vol 20, Num 1, pp 68-75, issn 1078-0432, 8 p.Article

Relapsed Classic E-Cadherin (CDH1)―Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene MutationsROSS, Jeffrey S; KAI WANG; YELENSKY, Roman et al.Clinical cancer research (Print). 2013, Vol 19, Num 10, pp 2668-2676, issn 1078-0432, 9 p.Article

Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable : application to mass spec dataPARK, Yuhyun; DOWNING, Sean R; KIM, Dohyun et al.Bioinformatics (Oxford. Print). 2007, Vol 23, Num 12, pp 1451-1458, issn 1367-4803, 8 p.Article